Development of iPSC-derived T cells targeting EGFR neoantigens in non-small cell lung cancer is a research paper published in Molecular Therapy — Methods & Clinical Development (2025). On theSindex it has a DataRank of 0.165. It has been cited 2 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.165
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →Lung Cancer Research Foundation
Grant: SPO 125372
National Institutes of Health
Grant: DP5OD024558
California Institute for Regenerative Medicine
Grant: LA1-06917
California Institute for Regenerative Medicine
Grant: DISC2-08874
National Institutes of Health
Grant: 5DP5OD024558-02
Developing approaches for universal organ transplantation
Kyushu University
Weston Havens Foundation
Japan Society for the Promotion of Science
Johns Hopkins University
Medizinische Universität Wien
National Defense Science and Engineering Graduate
University of Toronto
University of California, Los Angeles
FWCI
1.33
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals